Fortrea (NASDAQ:FTRE) Price Target Cut to $12.00 by Analysts at Barclays
Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...
Fortrea (NASDAQ:FTRE) Price Target Lowered to $11.00 at The Goldman Sachs Group
Fortrea (NASDAQ:FTRE – Get Free Report) had its target price decreased by analysts at The Goldman Sachs Group from $22.00 to ...
StockStory.org on MSN3d
Why Fortrea (FTRE) Shares Are Plunging Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after the company ...
Fortrea Holdings Inc. (NASDAQ:FTRE) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 3, 2025 Fortrea Holdings Inc. misses on earnings expectations. Reported EPS is $0.18 ...
What To Expect From Fortrea’s (FTRE) Q4 Earnings
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what ...
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Evolus (EOLS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fortrea Holdings Inc. (FTRE – Research ...
Evercore ISI Sticks to Their Hold Rating for Fortrea Holdings Inc. (FTRE)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report) yesterday and set a ...
Hosted on MSN3d
Fortrea (NASDAQ:FTRE) Misses Q4 Revenue Estimates, Stock Drops
Clinical research company Fortrea Holdings (NASDAQ:FTRE) in Q4 CY2024, with sales falling 1.8% year on year to $697 million.
Nasdaq3d
FORTREA Earnings Results: $FTRE Reports Quarterly Earnings
FORTREA ($FTRE) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.18 per share, missing estimates of $0.37 by $0.19. The ...